» Articles » PMID: 18255062

Inhibition of Endoplasmic Reticulum Stress Counteracts Neuronal Cell Death and Protein Aggregation Caused by N-terminal Mutant Huntingtin Proteins

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2008 Feb 8
PMID 18255062
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulation of abnormal proteins occurs in many neurodegenerative diseases including Huntington's disease (HD). However, the precise role of protein aggregation in neuronal cell death remains unclear. We show here that the expression of N-terminal huntingtin proteins with expanded polyglutamine (polyQ) repeats causes cell death in neuronal PC6.3 cell that involves endoplasmic reticulum (ER) stress. These mutant huntingtin fragment proteins elevated Bip, an ER chaperone, and increased Chop and the phosphorylation of c-Jun-N-terminal kinase (JNK) that are involved in cell death regulation. Caspase-12, residing in the ER, was cleaved in mutant huntingtin expressing cells, as was caspase-3 mediating cell death. In contrast, cytochrome-c or apoptosis inducing factor (AIF) was not released from mitochondria after the expression of these proteins. Treatment with salubrinal that inhibits ER stress counteracted cell death and reduced protein aggregations in the PC6.3 cells caused by the mutant huntingtin fragment proteins. Salubrinal upregulated Bip, reduced cleavage of caspase-12 and increased the phosphorylation of eukaryotic translation initiation factor-2 subunit-alpha (eIF2alpha) that are neuroprotective. These results show that N-terminal mutant huntingtin proteins activate cellular pathways linked to ER stress, and that inhibition of ER stress by salubrinal increases cell survival. The data suggests that compounds targeting ER stress may be considered in designing novel approaches for treatment of HD and possibly other polyQ diseases.

Citing Articles

The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer.

Talukdar G, Orr H, Lei Z Hum Mol Genet. 2023; 32(16):2545-2557.

PMID: 37384418 PMC: 10407711. DOI: 10.1093/hmg/ddad103.


Dimethyl fumarate abrogates striatal endoplasmic reticulum stress in experimentally induced late-stage Huntington's disease: Focus on the IRE1α/JNK and PERK/CHOP trajectories.

Hassab L, Abbas S, Mohammed R, Abdallah D Front Pharmacol. 2023; 14:1133863.

PMID: 37056990 PMC: 10088517. DOI: 10.3389/fphar.2023.1133863.


Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.

DEgidio F, Castelli V, Cimini A, dAngelo M Antioxidants (Basel). 2023; 12(3).

PMID: 36978821 PMC: 10045781. DOI: 10.3390/antiox12030571.


Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease.

Stepanova P, Kumar D, Cavonius K, Korpikoski J, Sirjala J, Lindholm D Sci Rep. 2023; 13(1):2953.

PMID: 36807563 PMC: 9941578. DOI: 10.1038/s41598-023-28798-4.


Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress.

Yoo Y, Joo S Int J Mol Sci. 2023; 24(3).

PMID: 36768703 PMC: 9916953. DOI: 10.3390/ijms24032381.